280 related articles for article (PubMed ID: 20023745)
1. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer.
Olson ES; Aguilera TA; Jiang T; Ellies LG; Nguyen QT; Wong EH; Gross LA; Tsien RY
Integr Biol (Camb); 2009 Jun; 1(5-6):382-93. PubMed ID: 20023745
[TBL] [Abstract][Full Text] [Related]
2. Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides.
Aguilera TA; Olson ES; Timmers MM; Jiang T; Tsien RY
Integr Biol (Camb); 2009 Jun; 1(5-6):371-81. PubMed ID: 20023744
[TBL] [Abstract][Full Text] [Related]
3. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
J Nucl Med; 2011 Feb; 52(2):279-86. PubMed ID: 21233187
[TBL] [Abstract][Full Text] [Related]
4. In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
Contrast Media Mol Imaging; 2015; 10(1):59-66. PubMed ID: 24823643
[TBL] [Abstract][Full Text] [Related]
5. Imaging of MMP activity in postischemic cardiac remodeling using radiolabeled MMP-2/9 activatable peptide probes.
van Duijnhoven SM; Robillard MS; Hermann S; Kuhlmann MT; Schäfers M; Nicolay K; Grüll H
Mol Pharm; 2014 May; 11(5):1415-23. PubMed ID: 24641497
[TBL] [Abstract][Full Text] [Related]
6. Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.
Shi NQ; Gao W; Xiang B; Qi XR
Int J Nanomedicine; 2012; 7():1613-21. PubMed ID: 22619516
[TBL] [Abstract][Full Text] [Related]
7. The targeted transduction of MMP-overexpressing tumor cells by ACPP-HPMA copolymer-coated adenovirus conjugates.
Li S; Chen J; Xu H; Long J; Xie X; Zhang Y
PLoS One; 2014; 9(7):e100670. PubMed ID: 25000246
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
10. Parallel in vivo and in vitro selection using phage display identifies protease-dependent tumor-targeting peptides.
Whitney M; Crisp JL; Olson ES; Aguilera TA; Gross LA; Ellies LG; Tsien RY
J Biol Chem; 2010 Jul; 285(29):22532-41. PubMed ID: 20460372
[TBL] [Abstract][Full Text] [Related]
11. Tumor imaging by means of proteolytic activation of cell-penetrating peptides.
Jiang T; Olson ES; Nguyen QT; Roy M; Jennings PA; Tsien RY
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17867-72. PubMed ID: 15601762
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer.
Grünwald B; Vandooren J; Locatelli E; Fiten P; Opdenakker G; Proost P; Krüger A; Lellouche JP; Israel LL; Shenkman L; Comes Franchini M
J Control Release; 2016 Oct; 239():39-48. PubMed ID: 27545397
[TBL] [Abstract][Full Text] [Related]
13. Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma.
Felsen CN; Savariar EN; Whitney M; Tsien RY
Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(8):L764-74. PubMed ID: 24508733
[TBL] [Abstract][Full Text] [Related]
14. Hydrolysis Mechanism of the Linkers by Matrix Metalloproteinase-9 Using QM/MM Calculations.
Chen B; Kang Z; Zheng E; Liu Y; Gauld JW; Wang Q
J Chem Inf Model; 2021 Oct; 61(10):5203-5211. PubMed ID: 34649435
[TBL] [Abstract][Full Text] [Related]
15. Dual targeting of integrin αvβ3 and matrix metalloproteinase-2 for optical imaging of tumors and chemotherapeutic delivery.
Crisp JL; Savariar EN; Glasgow HL; Ellies LG; Whitney MA; Tsien RY
Mol Cancer Ther; 2014 Jun; 13(6):1514-25. PubMed ID: 24737028
[TBL] [Abstract][Full Text] [Related]
16. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival.
Nguyen QT; Olson ES; Aguilera TA; Jiang T; Scadeng M; Ellies LG; Tsien RY
Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4317-22. PubMed ID: 20160097
[TBL] [Abstract][Full Text] [Related]
17. Gelatinase activity imaged by activatable cell-penetrating peptides in cell-based and in vivo models of stroke.
Chen S; Cui J; Jiang T; Olson ES; Cai QY; Yang M; Wu W; Guthrie JM; Robertson JD; Lipton SA; Ma L; Tsien RY; Gu Z
J Cereb Blood Flow Metab; 2017 Jan; 37(1):188-200. PubMed ID: 26681768
[TBL] [Abstract][Full Text] [Related]
18. Internalization of Near-Infrared Fluorescently Labeled Activatable Cell-Penetrating Peptide and of Proteins into Human Fibrosarcoma Cell Line HT-1080.
Tansi F; Kallweit E; Kaether C; Kappe K; Schumann C; Hilger I; Reissmann S
J Cell Biochem; 2015 Jul; 116(7):1222-31. PubMed ID: 25546737
[TBL] [Abstract][Full Text] [Related]
19. Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.
Hauff SJ; Raju SC; Orosco RK; Gross AM; Diaz-Perez JA; Savariar E; Nashi N; Hasselman J; Whitney M; Myers JN; Lippman SM; Tsien RY; Ideker T; Nguyen QT
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):612-8. PubMed ID: 25091190
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]